Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02341963 · ClinicalTrials.gov registry record · Phase 1
A Pilot Clinical Trial of Oral Ketamine for Acute Pain Management After Amputation Surgery
A Phase 1 study, sponsored by Rush University Medical Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT02341963 is a Phase 1 study that was terminated before completion, run by Rush University Medical Center. The registered enrollment target is 5 participants.
The verdict
NCT02341963, a Phase 1 study, was terminated before completion, sponsored by Rush University Medical Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to test the safety of oral ketamine to treat acute pain after amputation surgery. The objective of the proposed research is to conclusively determine if oral ketamine is a safe alternative analgesic to opioid for acute pain in subjects undergoing elective amputation of the lower extremity. All participants will receive oral ketamine.
Interventions
- DRUG Oral Ketamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-01 |
| Est. Completion | 2021-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02341963
The ClinicalTrials.gov registry entry for NCT02341963 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral Ketamine is the first listed.
NCT02341963 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02341963 about?
NCT02341963 is a clinical study titled "A Pilot Clinical Trial of Oral Ketamine for Acute Pain Management After Amputation Surgery". The purpose of this pilot study is to test the safety of oral ketamine to treat acute pain after amputation surgery. The objective of the proposed research is to conclusively determine if oral ketamine is a safe alternative analgesic to opioid for acute pain in subjects undergoing elective amputatio...
What is the current status of trial NCT02341963?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2015-01. Estimated completion is 2021-01.
What interventions are being tested in trial NCT02341963?
The interventions under investigation include: Oral Ketamine (DRUG).
Who is sponsoring clinical trial NCT02341963?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.